DataMeds AI, Inc. (MEDS)
3.04
-0.31
(-9.25%)
USD |
NASDAQ |
Oct 06, 16:00
3.06
+0.02
(+0.66%)
After-Hours: 20:00
DataMeds AI Cash from Investing (Quarterly) : -0.2421M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2421M |
| March 31, 2026 | -0.2051M |
| December 31, 2025 | -0.2554M |
| September 30, 2025 | -0.2211M |
| June 30, 2025 | -0.1319M |
| March 31, 2025 | -0.2731M |
| December 31, 2024 | 0.8384M |
| Date | Value |
|---|---|
| September 30, 2024 | -0.3159M |
| June 30, 2024 | -0.0534M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | 0.00 |
| Stella Diagnostics, Inc. | 0.00 |
| Interpace Biosciences, Inc. | -0.057M |
| Medical Marijuana, Inc. | 0.0026M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.894M |
| Cash from Financing (Quarterly) | 5.541M |
| Free Cash Flow | -14.66M |
| Free Cash Flow Per Share (Quarterly) | -1.218 |
| Free Cash Flow to Equity (Quarterly) | -7.012M |
| Free Cash Flow to Firm (Quarterly) | -1.575M |
| Free Cash Flow Yield | -219.7% |